The budget bill that was passed in the House last week calls for $2 trillion in federal spending cuts to be identified over the next decade, with $880 billion of that coming from the Energy and Commerce Committee's jurisdiction, which includes the Medicaid program.

Prescription drug manufacturers raised prices on nearly 600 drugs in January, according to an analysis by 46brooklyn Research. Among those medications impacted by the increases are drugs used to treat diabetes, HIV, COVID-19, and cancer, as well as other conditions.

President Donald Trump signed an executive order Tuesday to reinforce rules, put into place during his first term, that push hospitals and payers to make healthcare prices more transparent for patients. The order directs the Departments of the Treasury, Labor, and Health and Human Services to rapidly implement and enforce the Trump healthcare price transparency ...

The House is renewing a push to take on pharmacy benefit managers that play an important role in the cost of prescription drugs that has been heavily scrutinized by lawmakers amid industry consolidation and rising prices. A subcommittee of the House Energy & Commerce Committee held a hearing on Wednesday focused on possible legislative solutions ...

According to reporting by The Mercury News, one of California’s leading daily newspapers, about one-fourth of all health insurance claims in the Golden State were denied last year. Some may have been denied due to Artificial Intelligence (AI). However, new legislation prohibits health insurers from relying solely on AI to deny a claim based on medical necessity. ...

Last week, President Trump threatened tariffs on pharmaceuticals if manufacturers don’t relocate operations to the U.S. On Wednesday, the CEO of Eli Lilly stood with Trump’s commerce secretary in Washington, D.C., to announce a $27 billion plan to build four manufacturing “mega-sites” in the U.S. Why it matters: The commitment illustrates the dance much of Big Pharma is ...